From DCAT Value Chain Insights (VCI)
Piramal Pharma Solutions, part of Piramal Enterprises, has appointed John Fowler as its chief operating officer. As chief operating officer, Fowler will be responsible for global operations and research and development.
Most recently, Fowler served as the divisional chief executive officer of the Global Fine Chemicals business at Johnson Matthey (JM). There, he had responsibility for JM's Services (custom active pharmaceutical ingredient development, manufacturing, catalyst & chiral technologies), and products (generics development and manufacturing) portfolio. Before leading JM's Fine Chemical Division, Fowler held senior leadership roles in several business verticals at JM, including pharmaceutical materials and services, environmental catalysts and technologies, among others.
Source: Piramal Pharma Solutions
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription